Management of Extraglandular Manifestations of Primary Sjogren's Syndrome

被引:5
|
作者
Wu, Jason J. [1 ,2 ]
Carsons, Steven E. [1 ,3 ]
机构
[1] Winthrop Univ Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Mineola, NY 11501 USA
[2] Nassau Cty Med Ctr, E Meadow, NY 11554 USA
[3] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA
关键词
Sjogren's syndrome; Joint pain; NSAIDs; Anti-TNF; POLYUNSATURATED FATTY-ACIDS; DOUBLE-BLIND; CLINICAL-SIGNIFICANCE; RHEUMATOID-ARTHRITIS; FATIGUE; INVOLVEMENT; RITUXIMAB; VASCULITIS; EFFICACY;
D O I
10.1016/j.coms.2013.09.009
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Primary Sjogren's syndrome can have multiple extra-glandular manifestations ranging from mild to severe. Treatment for extra-glandular manifestations is organ specific and therapies are targeted based on the primary organs involved. Preferred treatment options used for extra-glandular manifestations of Sjogren's syndrome are usually extrapolated from the physician's experience in treating similar manifestations in other autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematous. The lack of immunomodulating disease modifying drugs in Sjogren's syndrome can be frustrating for patients dealing with extra-glandular manifestations, however recent advances in the field has made the future look promising for new therapeutic options.
引用
收藏
页码:101 / +
页数:10
相关论文
共 50 条
  • [41] The kaleidoscope of neurological manifestations in primary Sjogren's syndrome
    Alunno, A.
    Carubbi, F.
    Bartoloni, E.
    Cipriani, P.
    Giacomelli, R.
    Gerli, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) : S192 - S198
  • [42] Neurological manifestations of primary Sjogren's syndrome.
    Lafitte, C
    REVUE NEUROLOGIQUE, 1998, 154 (10) : 658 - 673
  • [43] DIVERSITY OF CLINICAL MANIFESTATIONS OF PRIMARY SJOGREN'S SYNDROME
    Sebastian, A.
    Wiland, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1080 - 1080
  • [44] Difference in the frequency of extraglandular manifestations is not detected in primary Sjogren syndrome patients classified according to immunological criteria.
    Aguilera, S
    Gonzalez, J
    Castillo, D
    Ottosson, L
    Tengner, P
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S305 - S305
  • [45] Management of Primary Sjogren's Syndrome
    Marshall, Leisa L.
    Stevens, Gregg A.
    CONSULTANT PHARMACIST, 2018, 33 (12): : 691 - 701
  • [46] Pediatric Primary Sjogren Syndrome Presenting With Extraglandular Features:A Case Report
    Zeng, Shuhan
    Cheng, Cheng
    Rong, Liping
    Xu, Yuanyuan
    Lin, Zhilang
    Xu, Lingling
    Zhuang, Hongjie
    Jiang, Xiaoyun
    PEDIATRIC NEPHROLOGY, 2023, 38 (07) : 2421 - 2421
  • [47] THE IFN BIOMARKER SIGLEC1 INDICATES EXTRAGLANDULAR MANIFESTATION IN PRIMARY SJOGREN'S SYNDROME
    Rose, T.
    Szelinski, F.
    Burmester, G.
    Hiepe, F.
    Biesen, R.
    Doerner, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 561 - 561
  • [48] CIRCULATING IGA-RHEUMATOID AND IGM-RHEUMATOID FACTORS IN PATIENTS WITH PRIMARY SJOGREN SYNDROME - CORRELATION TO EXTRAGLANDULAR MANIFESTATIONS
    MULLER, K
    OXHOLM, P
    HOIERMADSEN, M
    WIIK, A
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1989, 18 (01) : 29 - 31
  • [49] Interferon Gamma Signaling Is Associated with Development of Extraglandular Manifestations in Sjogren's Disease
    Nakamura, Hiroyuki
    Nakamura, Koki
    Amaike, Hidenori
    Nagahata, Ken
    Kanda, Masatoshi
    Takahashi, Hiroki
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4602 - 4605
  • [50] ARTHRITIS AS AN EXTRAGLANDULAR MANIFESTATION IN SJOGREN'S SYNDROME AND ASSOCIATED FACTORS
    Garcia, Maria-Virginia
    Rodriguez-Ariza, Daniel-Efren
    Munera Pena, Alejandro
    Arias Cadavid, Esteban
    Puentes, Juan-Camilo
    Ortiz-Pardey, Angelica
    Vallejo, Manuela
    Suarez, Luis
    Torres-Cuervo, Dania
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 : S24 - S24